×
Close
Sign Up
Login
Home
SCI Abstract
Library D
Events & Partner
WeMed
MDLA Events Platform
Events
Media Partners
Educational Partner
User Tools
FAQ/USER GUIDE
Language
English
中文/ Chinese
French
Português
Español
Arabic
Russian
Contact Us
×
Close
mdla_1
mdla_2
mdla_3
mdla_4
mdla_5
mdla_6
Categories
Pharmacology & Pharmacy
35706
Global Medical University
5176
Allergy
1823
Anatomy & Morphology
1634
Andrology
394
Anesthesia & Intensive Care
1288
Anesthesiology
5571
Audiology & Speech-Language Pathology
361
Behavioral Sciences
105
Biochemical Research Methods
7363
Biochemistry & Molecular Biology
30520
Biodiversity Conservation
317
Biology
8635
Biophysics
8373
Biotechnology & Applied Microbiology
8749
Cardiac & Cardiovascular Systems
31671
Cardiovascular & Respiratory Systems
1452
Cell & Tissue Engineering
709
Cell Biology
11351
Chemistry, Analytical
4351
Chemistry, Applied
11115
Chemistry, Medicinal
8789
Chemistry, Multidisciplinary
18664
Clinical Immunology & Infectious Disease
451
Clinical Medicine
9012
Clinical Neurology
16940
Clinical Psychology & Psychiatry
1323
Critical Care Medicine
3218
Dentistry, Oral Surgery & Medicine
13792
Dermatology
7655
Developmental Biology
7093
Ecology
651
Education, Scientific Disciplines
2035
Emergency Medicine
4214
Endocrinology, Metabolism & Nutrition
24895
Engineering, Biomedical
3825
Entomology
478
Environmental Medicine & Public Health
4724
Evolutionary Biology
267
Gastroenterology & Hepatology
12594
General & Internal Medicine
7084
Genetics & Heredity
15428
Geriatrics & Gerontology
5299
Gerontology
381
Health Care Sciences & Services
16272
Health Policy & Services
623
Hematology
5686
Immunology
25198
Infectious Diseases
14168
Integrative & Complementary Medicine
2979
Medical Ethics
1239
Medical Informatics
2265
Medical Laboratory Technology
433
Medicine, General & Internal
45077
Medicine, Legal
541
Medicine, Research & Experimental
18003
Microbiology
23582
Mycology
0
Nanoscience & Nanotechnology
5395
Neuroimaging
1383
Neurology
4626
Neurosciences
40587
Nursing
9901
Nutrition & Dietetics
7923
Obstetrics & Gynecology
8470
Oncology
53214
Ophthalmology
9870
Optics
4311
Orthopedics
11944
Orthopedics, Rehabilitation & Sports Medicine
1849
Otolaryngology
1604
Otorhinolaryngology
5008
Parasitology
1162
Pathology
5251
Pediatrics
21893
Peripheral Vascular Disease
4886
Pharmacology/Toxicology
12324
Physiology
9057
Polymer Science
569
Primary Health Care
853
Psychiatry
19469
Psychology
5393
Psychology, Applied
120
Psychology, Biological
375
Psychology, Clinical
822
Psychology, Developmental
263
Psychology, Educational
164
Psychology, Experimental
181
Psychology, Mathematical
0
Psychology, Multidisciplinary
1736
Psychology, Psychoanalysis
41
Psychology, Social
132
Public Health & Health Care Science
2258
Public, Environmental & Occupational Health
27707
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
12678
Radiology, Nuclear Medicine & Medical Imaging
8352
Rehabilitation
3177
Remote Sensing
0
Reproductive Biology
2906
Reproductive Medicine
1225
Research/Laboratory Medicine & Medical Technology
4055
Respiratory System
7555
Rheumatology
6117
Social Sciences, Biomedical
1233
Substance Abuse
2774
Surgery
34526
Toxicology
4461
Transplantation
945
Tropical Medicine
314
Urology & Nephrology
13227
Veterinary Sciences
35
Virology
2557
Zoology
0
Channels
PHARMACOECONOMICS-OPEN
260
Medrxiv - Pharmacology and Therapeutics
240
AAPS JOURNAL
296
ACTA PHARMACOLOGICA SINICA
526
ADVANCED DRUG DELIVERY REVIEWS
0
ANTIVIRAL RESEARCH
0
CANCER CHEMOTHERAPY AND PHARMACOLOGY
380
CHEMICO-BIOLOGICAL INTERACTIONS
943
CHEMMEDCHEM
258
CLINICAL PHARMACOKINETICS
367
CLINICAL PHARMACOLOGY & THERAPEUTICS
258
CNS DRUGS
243
CNS NEUROSCIENCE & THERAPEUTICS
116
DRUG DISCOVERY TODAY
220
DRUG METABOLISM AND DISPOSITION
409
DRUG RESISTANCE UPDATES
178
DRUG SAFETY
334
DRUGS
447
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
718
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
644
EUROPEAN JOURNAL OF PHARMACOLOGY
1454
INTERNATIONAL IMMUNOPHARMACOLOGY
2781
INTERNATIONAL JOURNAL OF PHARMACEUTICS
2002
JOURNAL OF CONTROLLED RELEASE
1301
JOURNAL OF ETHNOPHARMACOLOGY
2316
JOURNAL OF FOOD AND DRUG ANALYSIS
169
JOURNAL OF PHARMACEUTICAL ANALYSIS
434
NATURE REVIEWS DRUG DISCOVERY
615
NEUROPHARMACOLOGY
0
NEUROPSYCHOPHARMACOLOGY
721
NEUROTOXICOLOGY
0
PHARMACOGENOMICS
11
PHARMACOLOGY & THERAPEUTICS
369
PHARMACOTHERAPY
54
THERAPEUTIC ADVANCES IN CHRONIC DISEASE
87
TOXICOLOGY AND APPLIED PHARMACOLOGY
1
TOXICOLOGY IN VITRO
468
VALUE IN HEALTH
20
VASCULAR PHARMACOLOGY
0
ANNALS OF PHARMACOTHERAPY
130
ANTIBIOTICS-BASEL
1984
BIOMEDICAL CHROMATOGRAPHY
243
BIOPHARMACEUTICS & DRUG DISPOSITION
20
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES
0
CHEMOTHERAPY
81
CHINESE MEDICINE
406
CHIRALITY
73
CLINICAL NEUROPHARMACOLOGY
50
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT
129
CLINICAL THERAPEUTICS
52
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
55
DOSE-RESPONSE
78
DRUG DEVELOPMENT RESEARCH
121
EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE
305
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
716
HUMAN & EXPERIMENTAL TOXICOLOGY
105
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE
0
INTERNATIONAL JOURNAL OF TOXICOLOGY
36
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH
172
JOURNAL OF ANTIBIOTICS
271
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
392
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
30
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
170
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
1883
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
505
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
176
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
0
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
0
JOURNAL OF PHARMACOLOGICAL SCIENCES
0
JOURNAL OF PHARMACY AND PHARMACOLOGY
18
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
577
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
121
PHARMACOGENOMICS & PERSONALIZED MEDICINE
322
PHARMACOLOGY
125
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
0
SKIN PHARMACOLOGY AND PHYSIOLOGY
70
THERAPEUTIC ADVANCES IN DRUG SAFETY
22
THERAPEUTIC DRUG MONITORING
172
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH
40
INDIAN JOURNAL OF PHARMACOLOGY
16
JOURNAL OF APPLIED BIOMEDICINE
44
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
47
REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY
367
THERAPIE
366
SCIENTIA PHARMACEUTICA
108
ADMET AND DMPK
114
ADVANCED THERAPEUTICS
95
ADVANCES IN PHARMACOLOGY AND PHARMACY
148
ADVANCES IN TRADITIONAL MEDICINE
42
ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE
26
ASIAN JOURNAL OF PHARMACEUTICS
189
CANADIAN JOURNAL OF HOSPITAL PHARMACY
193
CURRENT DRUG THERAPY
28
EGYPTIAN PHARMACEUTICAL JOURNAL
42
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES
286
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL
79
INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION
212
JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH
164
JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY
29
JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES
124
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
297
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS
44
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES
39
JOURNAL OF PHARMACY PRACTICE
98
JOURNAL OF RESEARCH IN PHARMACY PRACTICE
40
RESEARCH JOURNAL OF PHARMACOGNOSY
104
PHARMACEUTICAL MEDICINE
69
PHARMACIA
143
PHARMACY
176
PHARMACY PRACTICE-GRANADA
31
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES
139
DRUGS & AGING
263
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
505
INVESTIGATIONAL NEW DRUGS
341
JOURNAL OF PHARMACEUTICAL INNOVATION
342
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
185
NEUROTHERAPEUTICS
355
PEDIATRIC DRUGS
195
THERAPEUTIC INNOVATION & REGULATORY SCIENCE
332
SCI Abstract
search
ALL
RECOMMENDED
+
Economic Impact of Bladder Cancer in the USA
Incidence and mortality for bladder cancer has changed very little over the past 20 years. Approximately 40% of patients w...
Pharmacoeconomics-open
comment
0
thumb_up
0
Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses
Identifying key differences between manufacturers’ submitted analysis and economic reanalysis by the Canadian Agency...
Pharmacoeconomics-open
comment
0
thumb_up
0
Digital Versus Paper-Based Consent from the UK NHS Perspective: A Micro-costing Analysis
The paper-based consent pathway can be associated with missing information, error, and inadequate patient comprehension. D...
Pharmacoeconomics-open
comment
0
thumb_up
0
Costs of Adverse Events in Patients with Advanced or Metastatic Renal Cell Carcinoma with First-Line Treatment
This study evaluated costs associated with adverse events (AEs) in previously untreated real-world patients with advanced ...
Pharmacoeconomics-open
comment
0
thumb_up
0
From Clinical to Non-clinical Outcomes in the Treatment of HIV: An Economic and Organizational Impact Assessment
The aim of this study was to define the economic and organizational impacts related to a broader utilization of bictegravi...
Pharmacoeconomics-open
comment
0
thumb_up
0
Economic Burden of Haemophilia from a Societal Perspective: A Scoping Review
Haemophilia is a rare genetic bleeding disorder that leads to musculoskeletal complications. The high cost of haemophilia ...
Pharmacoeconomics-open
comment
0
thumb_up
0
Health Economic Evaluation of Antimicrobial Stewardship, Procalcitonin Testing, and Rapid Blood Culture Identification in Sepsis Care: A 90-Day Model-Based, Cost-Utility Analysis
We evaluated the cost-effectiveness of a bundled intervention including an antimicrobial stewardship program (ASP), procal...
Pharmacoeconomics-open
comment
0
thumb_up
0
Burden of Disease of Breast Cancer in Italy: A Real-World Data Analysis
Breast cancer (BC) constitutes a significant public health challenge in Italy, with a considerable impact on healthcare re...
Pharmacoeconomics-open
comment
0
thumb_up
0
The Association between COVID-19 Status and Economic Costs in the Early Stages of the COVID-19 Pandemic: Evidence from a UK Symptom Surveillance Digital Survey
In the absence of a vaccination programme, the coronavirus disease 2019 (COVID-19) pandemic had substantial impacts on pop...
Pharmacoeconomics-open
comment
0
thumb_up
0
Economic Evaluation of Total Knee Replacement Compared with Non-Surgical Management for Knee Osteoarthritis in India
This study is an economic evaluation of total knee replacement (TKR) in comparison with non-surgical management in India. ...
Pharmacoeconomics-open
comment
0
thumb_up
0
Cost-Effectiveness of Nivolumab Plus Ipilimumab versus Chemotherapy for Previously Untreated Metastatic NSCLC Using Mixture-Cure Survival Analysis Based on CheckMate 227 5-Year Data
This study assessed the cost-effectiveness of nivolumab plus ipilimumab (NIVO+IPI) versus platinum-doublet chemotherapy (c...
Pharmacoeconomics-open
comment
0
thumb_up
0
Comparing Different Implementation Strategies for Collaborative Dementia Care Management in Terms of Patients’ Characteristics, Unmet Needs, and the Impact on Quality of Life and Costs in Germany
To compare the implementation of collaborative dementia care management (cDCM) across two settings regarding patients̵...
Pharmacoeconomics-open
comment
0
thumb_up
0
Health-Economic Modelling of Improved Behavior in Insulin Injection Technique in Belgium
Adequate insulin injection technique (IIT) is crucial to optimize the efficacy of diabetes therapy. Widespread non-practic...
Pharmacoeconomics-open
comment
0
thumb_up
0
Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological Considerations
It is well known that healthcare resource constraints influence the capacity to deliver care, affecting both the costs and...
Pharmacoeconomics-open
comment
0
thumb_up
0
What Does Pharmaceutical 3D Printing Cost? A Framework and Case Study with Hydrocortisone for Adrenal Insufficiency
Pharmaceutical three-dimensional printing (3DP) technology offers an automated platform that can be utilized to manufactur...
Pharmacoeconomics-open
comment
0
thumb_up
0
A Cost Evaluation of COVID-19 Remote Home Monitoring Services in England
Remote home monitoring services emerged as critical components of health care delivery from NHS England during the COVID-1...
Pharmacoeconomics-open
comment
0
thumb_up
0
Using a Patient-Centered Multicriteria Decision Analysis to Assess the Value of Multiple Sclerosis Treatments in the US: A Study Protocol
The engagement of patients and family caregivers in value assessment is pivotal since they provide valuable contributions ...
Pharmacoeconomics-open
comment
0
thumb_up
0
Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata
For many decision makers in Health Technology Assessment the EQ-5D-5L is the standard measure of health-related quality of...
Pharmacoeconomics-open
comment
0
thumb_up
0
ENTIMOS: Decision Support Tool Highlights Potential Impact of Non-intravenous Therapies for Multiple Sclerosis on Patient Care via Clinical Scenario Simulation
Administration of intravenous (IV), high-efficacy treatments (HETs) for the treatment of multiple sclerosis (MS) poses a h...
Pharmacoeconomics-open
comment
0
thumb_up
0
A Cost-Effectiveness Analysis of Adjuvant Nivolumab for Patients with Resected Esophageal Cancer or Gastroesophageal Junction Cancer in France
Esophageal and gastroesophageal junction cancer (EC/GEJC) is a poor prognosis disease with a high risk of recurrence even ...
Pharmacoeconomics-open
comment
0
thumb_up
0
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story
Healthcare sustainability is a global challenge. Various value-driven healthcare strategies have been implemented by Singa...
Pharmacoeconomics-open
comment
0
thumb_up
0
Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina
The aim of this study was to perform a budget impact analysis (BIA) of introducing olaparib treatment for adult patients w...
Pharmacoeconomics-open
comment
0
thumb_up
0
Healthcare Resource Utilization and Associated Costs During the First 5 Years After Diagnosis and at the End of Life: A Nationwide Cohort Study of Patients with Multiple Myeloma in Finland
The burden associated with the treatment of patients with multiple myeloma (MM) is expected to increase due to the aging p...
Pharmacoeconomics-open
comment
0
thumb_up
0
Artificial-Intelligence Cloud-Based Platform to Support Shared Decision-Making in the Locoregional Treatment of Breast Cancer: Protocol for a Multidimensional Evaluation Embedded in the CINDERELLA Clinical Trial
Shared decision-making (SDM) plays a crucial role in breast cancer care by empowering patients and reducing decision regre...
Pharmacoeconomics-open
comment
0
thumb_up
0
Publisher Correction: Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison Between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International ...
Pharmacoeconomics-open
comment
0
thumb_up
0
Estimation of Health State Utility Values for Immunoglobulin A Nephropathy: A Time Trade-Off Analysis
Immunoglobulin A nephropathy (IgAN) is a rare progressive disease that can lead to kidney failure. The current study aimed...
Pharmacoeconomics-open
comment
0
thumb_up
0
Cost-Utility and Budget Impact Analysis of Adding SGLT-2 Inhibitors to Standard Treatment in Type 2 Diabetes Patients with Heart Failure: Utilizing National Database Insights from Thailand
Heart failure (HF) in type 2 diabetes (T2D) patients poses a significant clinical and financial burden. While sodium-gluco...
Pharmacoeconomics-open
comment
0
thumb_up
0
Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany
Haemophilia B is a rare genetic disease that is caused by a deficiency of coagulation factor IX (FIX) in the blood and lea...
Pharmacoeconomics-open
comment
0
thumb_up
0
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older
The aim of this study was to update previously estimated public health impact and cost effectiveness of recombinant zoster...
Pharmacoeconomics-open
comment
0
thumb_up
0
Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus
This study aims to estimate the budget impact of luspatercept reimbursement as an adjuvant to the standard management of &...
Pharmacoeconomics-open
comment
0
thumb_up
0
Load More
Modal title
×
Modal title
×
Share
Login
Global News and Health Forum
Join Now!
Member Login
Remember me
Forgot password?
Or using
Linkedin